2026年02月

The Gulf Cooperation Council is witnessing a pharmaceutical transformation unlike anything seen before. National strategies across Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE are accelerating breakthroughs in gene therapy, precision medicine, ... もっと読む

Medical Affairs Intelligence: Shaping the Future of Pharma in MENAIn the rapidly evolving pharmaceutical industry, Medical Affairs Intelligence (MAI) has emerged as a critical pillar, bridging scientific innovation with strategic decision-making. At its e ... もっと読む

The recent UAE approval of Tolebrutinib represents a watershed moment for neurology therapeutics across the Middle East and North Africa region. This oral Bruton's tyrosine kinase (BTK) inhibitor, authorized for non-relapsing secondary progressive multipl ... もっと読む

Healthcare Evolution in the Middle East: From Tradition to InnovationHealthcare in the Middle East has experienced a remarkable transformation over the past century, evolving from basic community-based practices to advanced, technology-driven systems. His ... もっと読む

IntroductionOver recent decades, the global healthcare industry has witnessed a remarkable geographic shift. The traditional centers of pharmaceutical innovation and medical excellence in North America and Western Europe are now sharing the stage with eme ... もっと読む

↑このページのトップヘ